Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix Inc.
WKN: A1180P / Symbol: OCUL / Name: Ocular / Aktie / Ausrüstung & Versorgung / Small Cap /
12,41 €
-0,20 %
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $15.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $17.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its price target lowered by analysts at Needham & Company LLC from $15.00 to $14.00. They now have a "buy" rating on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its price target raised by analysts at Needham & Company LLC from $14.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $21.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) had its price target raised by analysts at Needham & Company LLC from $15.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) had its price target raised by analysts at TD Cowen from $14.00 to $20.00. They now have a "buy" rating on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $20.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Neueste Beiträge
Wells_Fargo___Compan in Weight Watchers International diskutieren